Drug intelligence / Profile preview

biatain ag

Development stage
Unknown
Lead developer
Coloplast
Administration
Topical
01

Overview

**Biatain Ag** is a soft, absorbent polyurethane foam dressing containing a patented silver complex, designed to provide a broad antimicrobial effect in the management of moderately to highly exuding acute and chronic wounds. When the foam dressing comes into contact with wound exudate, silver ions are continuously released into the wound bed, exerting antimicrobial activity against a wide spectrum of bacteria, including MRSA, VRE, and Pseudomonas, for up to 7 days. The foam’s 3D structure ensures optimal absorption and retention of exudate, reducing peri-wound maceration and the risk of infection. Biatain Ag is indicated for wounds at risk of delayed healing due to bacteria, such as leg ulcers, pressure ulcers, diabetic foot ulcers, second-degree burns, donor sites, postoperative wounds, skin abrasions, and can be used in conjunction with compression therapy. The primary mechanism is the local release of ionic silver, which acts as a preservative and antimicrobial agent within the dressing, thus supporting wound healing and serving as a barrier to bacterial penetration[4][7][9].

Brand names
Biatain Ag
Other names
Biatain SilverBiatain Ag FoamBiatain Ag Non-Adhesive Foam

Beyond the preview

Go deeper on biatain ag.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on biatain ag.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call